.webp&w=828&q=75)
Bapcor’s FY26 turnaround shows improving sales momentum, lower debt, tighter pricing controls and stronger stock availability, though weak earnings, execution risks and cost pressures mean the recovery still needs further proof.

Objective Corporation delivered higher FY2026 revenue and earnings, but lost contracts, weaker recurring revenue and a softer FY2027 outlook have shifted attention toward whether AI, government software and new projects can restore growth.
.webp&w=828&q=75)
X2M Connect is expanding beyond smart metering into AI-enabled data centres, energy management and infrastructure services. A binding A$250 million-plus AI data centre agreement and new Seoul contracts boost growth potential, but execution, approvals, funding and profitability remain key risks.
.webp&w=828&q=75)
Golden Deeps is advancing deeper drilling at Graceland after encouraging copper, silver and zinc results. Fresh assays and new targets have strengthened interest in the Namibian exploration program, while upcoming drilling will test the discovery’s potential scale.

IGO (ASX: IGO) delivers strong FY26 results with disciplined execution, expanding margins at Greenbushes and Nova, and strategic portfolio optimisation aligned with global energy transition.

AVITA Medical is strengthening its commercial position as revenue growth improves, cash burn reduces, and its regenerative medicine portfolio expands. The company’s progress in product adoption and operational efficiency keeps it positioned as a speculative healthcare growth story.